A Multicenter, Open-Label Phase II Clinical Trial of Combined MEK plus EGFR Inhibition for Chemotherapy-Refractory Advanced Pancreatic Adenocarcinoma
暂无分享，去创建一个
E. Collisson | R. Kelley | M. Tempero | A. Venook | T. Bekaii-Saab | W. Korn | A. Ko | P. Kuhn | Ryan Courtin | Sharvina Ziyeh | S. Tahiri | E. Dito | A. Ong | Regina Linetskaya | N. Joseph | Amirali Talasaz | J. Van Ziffle | Olga M Mirzoeva